Our immunohistochemical results from 15 CRC patients accordingly showed that ACY1 protein levels were markedly increased in malignant epithelial cells but not in paracancerous tissues and were related to lymph node metastasis and cetuximab resistance, suggesting a distinct function of ACY1 in malignant transformation. The gene discussed is ACY1; the disease is colorectal carcinoma.